October 22, 2011
Multiple sclerosis diagnosis turned her life upside-down
- /
- /
Imagine waking up numb. So numb, in fact, that movement is either impossible or takes all your energy. If you…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
October 22, 2011
In study, Lemtrada helps MS patients
- /
- /
Oct 22, 2011 New data from a late-stage trial showed that 78 percent of patients treated with Lemtrada remained relapse-free…
October 22, 2011
One of the scientists at Biogen Idec pushing for a new kind of regenerative medicine for Multiple Sclerosis
- /
- /
- /
Luke Timmerman 10/21/11 Sha Mi, Biogen Idec’s Neurology Ace, to Join “The Genetics Institute Impact” conference One of the scientists at…
October 22, 2011
Genentech announces 96-week results from ocrelizumab Phase II study on RRMS
- /
- /
October 21, 2011 Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced 96-week results from…
October 22, 2011
Clinical and MRI Outcomes in Patients With MS, Treated with Fingolimod
- /
- /
- /
AMSTERDAM—Fingolimod at an oral dose of 0.5 mg consistently improved relapse rates, disability, and MRI outcomes compared with placebo or…
October 22, 2011
Approximately One-Third of MS Patients Experiencing Relapses Do Not Adequately Respond to Traditional Corticosteroid Therapy
- /
- /
–Survey conducted by the North American Research Committee on Multiple Sclerosis (NARCOMS)– AMSTERDAM, Oct. 21, 2011 /PRNewswire/ — On October 21 at the 5th Joint…
October 22, 2011
Natalizumab (Tysabri)-Associated PML Survival Rates Exceed 80%
- /
- /
- /
AMSTERDAM—Early diagnosis through enhanced clinical vigilance and optimal management of progressive multifocal leukoencephalopathy (PML) may improve outcomes, according to data…
October 22, 2011
Athersys has entered a partnership with a nonprofit multiple sclerosis group to investigate its adult stem cell technology for the treatment of MS
- /
- /
Fast Forward, a nonprofit subsidiary of the National Multiple Sclerosis Society, will commit up to $640,000 to fund animal studies…
October 21, 2011
Optic Neuritis – The definition
- /
- /
Definition Optic neuritis is a vision disorder characterized by inflammation of the optic nerve. Description Optic neuritis occurs when the…
October 21, 2011
SURVEY FINDS MAJORITY OF PEOPLE WITH MULTIPLE SCLEROSIS REPORT DIFFICULTY WALKING OR MAINTAINING BALANCE
- /
- /
Most people know that multiple sclerosis eventually leads to trouble walking. A new survey of more than 1,200 adults living…
